Prevalence of diabetes in Northern African countries: the case of Tunisia

BMC Public Health

Noureddine Achour³  Francis Delpeuch²  Bernard Maire²  Souha Bougatef³  Hajer Aounallah-Skhiri¹  Pierre Traissac²  Wafa Aissi³  Samir Ben Ali³  Habiba Ben Romdhane³ 

[1]National Public Health Institute, 7 rue Khartoum, Tunis 1005, Tunisia

[2]IRD (Institut de Recherche pour le Développement), UMR 204 NUTRIPASS, IRD-UM1-UM2, 911, av. Agropolis, 34394 Montpellier, France

[3]Cardiovascular Epidemiology and Prevention Research Laboratory, Faculty of Medicine, 15 rue Djebel Akdhar-La Rabta-1007 Bab Saâdoun, Tunis, Tunisia

关键词: Sociodemographic factors;    Impaired fasting glucose;    Undiagnosed;    Diagnosed;    Type 2 Diabetes;    Prevalence;   

Others  :  1161298
DOI  :  10.1186/1471-2458-14-86

 received in 2012-08-31, accepted in 2013-11-26,  发布年份 2014

【 摘 要 】

Background

Although diabetes is recognized as an emerging disease in African and Middle East, few population-based surveys have been conducted in this region. We performed a national survey to estimate the prevalence of type 2 diabetes (T2D) and to evaluate the relationship between this diagnosis, demographic and socioeconomic variables.

Methods

The study was conducted on a random sample of 6580 households (940 in each region). 7700 subjects adults 35–70 years old were included in the analyses. T2D was assessed on the basis of a questionnaire and fasting blood glucose level according to the WHO criteria. Access to health care and diabetes management were also assessed.

Results

Overall, the prevalence of T2D was 15.1%. There were sharp urban vs. rural contrasts, the prevalence of diabetes being twice higher in urban area. However, the ratio urban/rural varied from 3 in the less developed region to 1.6 in the most developed ones. A sharp increase of prevalence of T2D with economic level of the household was observed. For both genders those with a family history of T2D were much more at risk of T2D than those without. Awareness increase with age, economic level and were higher amongst those with family history of T2D. Drugs were supplied by primary health care centers for 57.7% with a difference according to gender, 48.9% for men vs. 66.0% women (p < 0.001) and area, 53.3% on urban area vs. 75.2% on rural one (p < 0.001).

Conclusions

Through its capacity to provide the data on the burden of diabetes in the context of the epidemiological transition that North Africa is facing, this survey will not only be valuable source for health care planners in Tunisia, but will also serve as an important research for the study of diabetes in the region where data is scarce. In this context, NCDs emerge as an intersectoral challenge and their social determinants requiring social, food and environmental health policy.

【 授权许可】

   
2014 Ben Romdhane et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet 1997, 349:1498-1504.
• [2]Gaziono TA, Bitton A, Anoud S, Abrahms-Gessel SH, Murphy A: Growing epidemic of coronary heart disease in low-and middle income countries. Curr Probl Cordial 2010, 35:72-115.
• [3]UNDP: Human Development UNDP Report. 2009. Website. http://hdrstats.undp.org/en/countries/country_fact_sheets/cty_fs_TUN.html webcite (Accessed 25 December, 2011)
• [4]National Institute of Statistics Tunisia: Yearly statistics report. 2009. N° 52. http://www.ins.nat.tn/indexfr.php webcite
• [5]Ben Romdhane H, Khaldi R, Oueslati A, Skhiri H: Epidemiologic and nutritional transition in Tunisia. Options Méditerranéennes 2002, 41:278.
• [6]National Public Health Institute: Deaths Registry Report. Tunisia; 2011.
• [7]Ben Romdhane H: Coronary Heart Diseases: the epidemic and its determinants. In vol I: the risk factors. Tunis: National Public Health Institute; 2001.
• [8]Elasmi M, Feki M, Senhaji H, Jemaa R, Hej Taieb S, Omar S, Mbazaa A, El Ati J, Hsairi M, Kaabachi N: Prévalence des facteurs de risque cardiovasculaires conventionnels dans la population du grand Tunis. Revue d’épidémiologie et santé publique 2009, 57:92-87.
• [9]Bouguerra R, Alberti H, Ben Salem L, Ben Rayana C, El Atti J, Gaigi S, Ben Slama C, Zouari B, Alberti K: The global diabetes pandemic: the Tunisian experience. Eur J Clin Nutr 2007, 61:160-165.
• [10]Levy PS, Lemeshow S: Sampling of populations. Methods and applications. New York: John Wiley & Sons; 1999.
• [11]National Statistics Institute of Tunisia: Results of the 2004 census. http://www.ins.nat.tn/indexen.php webcite (Accessed 25 December, 2011)
• [12]WHO Consultation Report: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: Department of Non communicable Disease Surveillance, WHO; 1999. http://whqlibdoc.who.int/hq/1999/who_ncd_ncs_99.2.pdf webcite
• [13]Lauritsen JM: EpiData Data Entry, Data Management and basic Statistical Analysis System. Odense Denmark: EpiData Association; 2000–2008. Available: http://www.epidata.dk webcite
• [14]StataCorp: Stata Statistical Software: Release 12.0. College Station, Texas: Stata Corporation; 2011.
• [15]Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousi Lahti P: Increasing prevalence of DM in Oman. Diabetes Med 2002, 19:954-957.
• [16]Bener A, Zirie M, Janahi IM, Al-Hamaq A, Musallam M, Wareham NJ: Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diab Res Clin Pract 2009, 84:99-106.
• [17]Hamdeh RR: Non-communicable diseases among the Bahraini population: a review. East Mediterr Health J 2000, 6:1091-1097.
• [18]Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al- Harthi SS, Arafah MR, Khalil MZ, et al.: Diabetes mellitus in Saudi Arabia. Saudi Med J 2004, 25:1603-1610.
• [19]Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, et al.: Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, UAE. Diab Res Clin Pract 2007, 78:369-377.
• [20]Golozar A, Khademi H, Kamangar F, Poutschi H, Islami F, Abnet CC, Freedman ND, Taylor PR, Pharoah P, Boffetta P, Brennan PJ, et al.: Diabetes mellitus and its correlates in an Iranian adult population. Plos One 2011, 6:e26725.
• [21]Malek R, Balatech F, Laouamri S, Hamdi-Cherif M, Touabli A, Bendib W, et al.: Prevalence of type 2 diabetes mellitus and glucose intolerance in the Setif area (Algeria). Diabetes Metab 2001, 27:164-171.
• [22]Loizou T, Pouloukas S, Tountas C, Thanopoulou A, Karamanos V: An epidemiologic study on the prevalence of diabetes, glucose tolerance and metabolic syndrome in the adult population of the republic of Cyprus. Diabetes Care 2006, 29:1714-1715.
• [23]Boronat M, Varillas VF, Saavedra P, Suarez V, Bosch E, Carrillo A, et al.: DM and impaired glucose regulation in the Canary islands (Spain) prevalence and associated factors in the adult population of Telde, Gran Canaria. Diab Med 2005, 23:148-155.
• [24]Faeh D, William J, Tappy L, Ravussin E, Bovet P: Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health 2007, 7:163. BioMed Central Full Text
• [25]Sekikawa A, Eguchi H, Tominaga M, Igarashi K, Abe T, Manaka H, et al.: Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan, The Funagata Diabetes Study. J Diabetes Complications 2000, 14:78-83.
• [26]Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, Khodaee G, Hosseini J, Abasalti Z, Hassankhani B, Ferns G: Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J 2008, 49:571-576.
• [27]Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, Lim SC, Tai ES, Mitchell P: Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008, 115:1869-1875.
• [28]Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
• [29]King H, Aubert RE, Herman WH: Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
• [30]Ben Romdhane H, Grenier F: Social determinants of health in Tunisia: the case-analysis of Ariana. Int J Equity Health 2009, 8:9. BioMed Central Full Text
• [31]Ben Romdhane H, Belhani HH, et al.: Epidemiological Transition in Tunisia: its determinants and health impact. Tunis Med 2005, 83:1-7.
• [32]Ong KL, Cheung BM, Wong LY, Wat NM, Tan KC, Lam KS: Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004. Ann Epidemiol 2008, 18:222-229.
• [33]Sims M, Diez Roux AV, Boykin S, Sarpong D, Gebreab SY, Wyatt SB, Hickson D, Payton M, Ekunwe L, Taylor HA: The socioeconomic gradient of diabetes prevalence, awareness, treatment, and control among African Americans in the Jackson Heart Study. Ann Epidemiol 2011, 21:892-898.
• [34]Yoon PW, Scheuner MT, Peterson-Ochlke KL, Gwinn M, Faucett A, Khoury MJ: Can family history be used as a tool for public health and preventive medicine? Genet Med 2002, 4:304-310.
• [35]Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, et al.: The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle study. Diabetes Care 2002, 25:829-834.
• [36]Glumer C, Jorgensen T, Borch-Johnsen K: Prevalences of diabetes and impaired glucose regulation in a Danish population: the inter 99 study. Diabetes Care 2003, 26:2335-2340.
• [37]Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S, Ganesan A, et al.: Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban south India, the Chennai, Urban Rural epidemiology study (CURES 17). Diabetologia 2006, 49:1175-1178.